University of Hawaii Awarded $1.8M to Predict Risk of Chemotherapy Side Effects
December 17, 2021
December 17, 2021
HONOLULU, Hawaii, Dec. 17 (TNSRes) -- The University of Hawaii issued the following news release:
A $1.8 million National Cancer Institute grant awarded to the University of Hawaii Cancer Center will help determine how epigenetic age (age based on DNA biomarkers) can be used to predict the risk of chemotherapy side effects and if the rate of epigenetic aging can be reduced over treatment. UH researcher Alexandra Binder and collaborators hope to use their findings to improve health o . . .
A $1.8 million National Cancer Institute grant awarded to the University of Hawaii Cancer Center will help determine how epigenetic age (age based on DNA biomarkers) can be used to predict the risk of chemotherapy side effects and if the rate of epigenetic aging can be reduced over treatment. UH researcher Alexandra Binder and collaborators hope to use their findings to improve health o . . .